Found: 76
Select item for more details and to access through your institution.
Osimertinib With Ramucirumab in EGFR-mutated, T790M-positive Patients With Progression During EGFR-TKI Therapy: Phase Ib Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Docetaxel Plus RAmucirumab With Primary Prophylactic Pegylated Granulocyte-ColONy Stimulating Factor Support for Elderly Patients With Advanced Non-small-cell Lung Cancer: A Multicenter Prospective Single Arm Phase II Trial: DRAGON Study (WJOG9416L).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Exacerbation of autoimmune hemolytic anemia induced by the first dose of programmed death-1 inhibitor pembrolizumab: a case report.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 3, p. 509, doi. 10.1007/s10637-018-0561-5
- By:
- Publication type:
- Article
Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 3, p. 253, doi. 10.1007/s10637-006-9012-9
- By:
- Publication type:
- Article
Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trial.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 2, p. 151, doi. 10.1007/s10637-006-5937-2
- By:
- Publication type:
- Article
A phase III open-label study to assess safety and efficacy of palonosetron for preventing chemotherapy-induced nausea and vomiting (CINV) in repeated cycles of emetogenic chemotherapy.
- Published in:
- Supportive Care in Cancer, 2012, v. 20, n. 7, p. 1507, doi. 10.1007/s00520-011-1239-0
- By:
- Publication type:
- Article
A multicenter, randomized, controlled, single-blind comparison phase III study to determine the efficacy and safety of gadobutrol 1.0 M versus gadopentetate dimeglumine following single injection in patients referred for contrast-enhanced MRI of the body regions or extremities
- Published in:
- Journal of Magnetic Resonance Imaging, 2015, v. 41, n. 2, p. 404, doi. 10.1002/jmri.24566
- By:
- Publication type:
- Article
Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis.
- Published in:
- Clinical & Experimental Metastasis, 2014, v. 31, n. 5, p. 543, doi. 10.1007/s10585-014-9648-3
- By:
- Publication type:
- Article
Clinical Features and Outcome of Acute Exacerbation of Interstitial Pneumonia: Collagen Vascular Diseases-Related versus Idiopathic.
- Published in:
- Respiration, 2012, v. 83, n. 1, p. 20, doi. 10.1159/000329893
- By:
- Publication type:
- Article
Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosis.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00582-1
- By:
- Publication type:
- Article
Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Evaluation of the effect of compression therapy using surgical gloves on nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a phase II multicenter study by the Kamigata Breast Cancer Study Group.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 160, n. 1, p. 61, doi. 10.1007/s10549-016-3977-7
- By:
- Publication type:
- Article
Relationship between Paronychia and Drug Concentrations of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
- Published in:
- Oncology, 2018, v. 95, n. 4, p. 251, doi. 10.1159/000490177
- By:
- Publication type:
- Article
Prospective analysis of the association between skeletal-related events and quality of life in patients with advanced lung cancer (CSP-HOR13).
- Published in:
- Oncology Letters, 2019, v. 17, n. 1, p. 1320
- By:
- Publication type:
- Article
Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-05626-2
- By:
- Publication type:
- Article
A multi-center, Phase II trial of nab-paclitaxel and gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 7135, doi. 10.2147/CMAR.S208224
- By:
- Publication type:
- Article
Dose reduction in cone-beam CT scanning for intracranial stent deployment before coil embolization of intracranial wide-neck aneurysms.
- Published in:
- Interventional Neuroradiology, 2016, v. 22, n. 4, p. 420, doi. 10.1177/1591019916632489
- By:
- Publication type:
- Article
Overall survival analysis of patients enrolled in a randomized phase III trial comparing gefitinib and erlotinib for previously treated advanced lung adenocarcinoma (WJOG5108LFS).
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 1, p. 79, doi. 10.1007/s10147-022-02266-x
- By:
- Publication type:
- Article
Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB–IIIA non-small cell lung cancer (WJTOG0101).
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 12, p. 2216, doi. 10.1007/s10147-021-02012-9
- By:
- Publication type:
- Article
Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer.
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 1, p. 70, doi. 10.1007/s10147-016-1039-0
- By:
- Publication type:
- Article
Erratum to: Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer.
- Published in:
- 2017
- By:
- Publication type:
- Erratum
Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined by titration for the treatment of breakthrough pain in Japanese cancer patients: a multicenter, randomized, placebo-controlled, double-blind phase III trial.
- Published in:
- International Journal of Clinical Oncology, 2015, v. 20, n. 1, p. 198, doi. 10.1007/s10147-014-0697-z
- By:
- Publication type:
- Article
Oesophagobronchial perforations after placement of an oesophageal self‐expanding metallic stent.
- Published in:
- Respirology Case Reports, 2020, v. 8, n. 4, p. 1, doi. 10.1002/rcr2.554
- By:
- Publication type:
- Article
Phase I/II Study of Osimertinib With Bevacizumab in EGFR-mutated, T790M-positive Patients With Progressed EGFR-TKIs: West Japan Oncology Group 8715L (WJOG8715L).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Single nucleotide variant sequencing errors in whole exome sequencing using the Ion Proton System.
- Published in:
- Biomedical Reports, 2017, v. 7, n. 1, p. 17, doi. 10.3892/br.2017.911
- By:
- Publication type:
- Article
Three‐year follow‐up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non‐small cell lung cancer: Pooled analysis of ONO‐4538‐05 and ONO‐4538‐06 studies.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 11, p. 5183, doi. 10.1002/cam4.2411
- By:
- Publication type:
- Article
Validation of the digital PCR system in tyrosine kinase inhibitor‐resistant <italic>EGFR</italic> mutant non‐small‐cell lung cancer.
- Published in:
- Pathology International, 2018, v. 68, n. 3, p. 167, doi. 10.1111/pin.12630
- By:
- Publication type:
- Article
Afatinib plus bevacizumab combination after acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: Multicenter, single-arm, phase 2 trial (ABC Study).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Rebiopsy of non-small cell lung cancer patients with acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor: Comparison between T790M mutation-positive and mutation-negative populations.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Rebiopsy of non-small cell lung cancer patients with acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 24, p. 4325, doi. 10.1002/cncr.28364
- By:
- Publication type:
- Article
A phase 3 study of induction treatment with concurrent chemoradiotherapy versus chemotherapy before surgery in patients with pathologically confirmed N2 stage IIIA nonsmall cell lung cancer (WJTOG9903).
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 24, p. 6126, doi. 10.1002/cncr.26689
- By:
- Publication type:
- Article
Assessment of exposure risk of irinotecan and its active metabolite, SN-38, through perspiration during chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 865, doi. 10.1177/1078155218769136
- By:
- Publication type:
- Article
Medroxyprogesterone Acetate for Refractory Emesis in Cisplatin-Treated Patients.
- Published in:
- Journal of Palliative Medicine, 2012, v. 15, n. 10, p. 1158, doi. 10.1089/jpm.2011.0527
- By:
- Publication type:
- Article
A Phase II Study of Pemetrexed in Chemotherapy-naïve Elderly Patients Aged ≥75 years with Advanced Non-squamous Non-small-cell Lung Cancer (HANSHIN Oncology Group 003).
- Published in:
- Japanese Journal of Clinical Oncology, 2013, v. 43, n. 12, p. 1184, doi. 10.1093/jjco/hyt159
- By:
- Publication type:
- Article
Erlotinib for Pretreated Squamous Cell Carcinoma of the Lung in Japanese Patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 12, p. 1366, doi. 10.1093/jjco/hyr159
- By:
- Publication type:
- Article
Phase II Study of Gefitinib as a First-line Therapy in Elderly Patients with Pulmonary Adenocarcinoma: West Japan Thoracic Oncology Group Study 0402†.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 8, p. 948
- By:
- Publication type:
- Article
A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancerpatients treated with platinum-based doubletc hemotherapy.
- Published in:
- BMC Medical Genetics, 2010, v. 11, p. 167, doi. 10.1186/1471-2350-11-167
- By:
- Publication type:
- Article
Successful Treatment of a Mixed Neuroendocrine-Nonneuroendocrine Neoplasm of the Colon with Metastases to the Thyroid Gland and Liver.
- Published in:
- Case Reports in Otolaryngology, 2020, p. 1, doi. 10.1155/2020/5927610
- By:
- Publication type:
- Article
Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 1, p. 106, doi. 10.1093/jjco/hyaa157
- By:
- Publication type:
- Article
Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Pemetrexed monotherapy for chemo-naïve elderly (aged ≥80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003).
- Published in:
- 2017
- By:
- Publication type:
- journal article
EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A phase II study of pemetrexed monotherapy in chemo-naïve Eastern Cooperative Oncology Group performance status 2 patients with EGFR wild-type or unknown advanced non-squamous non-small cell lung cancer (HANSHIN Oncology Group 002)
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
A phase II study of pemetrexed monotherapy in chemo-naïve Eastern Cooperative Oncology Group performance status 2 patients with EGFR wild-type or unknown advanced non-squamous non-small cell lung cancer (HANSHIN Oncology Group 002).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1267, doi. 10.1007/s00280-015-2755-2
- By:
- Publication type:
- Article
High-dose erlotinib for refractory leptomeningeal metastases after failure of standard-dose EGFR-TKIs.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1261, doi. 10.1007/s00280-015-2759-y
- By:
- Publication type:
- Article